In this Issue:
Vericiguat and NT-proBNP levels in worsening chronic HFREF
HF in Africa, Asia, the Middle East and South America
G-CSF + bone marrow cells in nonischaemic dilated cardiomyopathy
Adding point-of-care ultrasound to assess volume status in HF
Prognostic value of NT-proBNP and FGF-23 in HFPEF vs. HFREF
Restoring pulsatile flow via continuous-flow LVADs reduces sympathetic nerve activity
Fully magnetically levitated LVAD for advanced HF
HFREF, not HFPEF, benefits from NT-proBNP-guided therapy
Lateral sleep position reduces CSA/OSA severity in HF
Please login below to download this issue (PDF)